ANO Shares Advance ZincTek Limited
ASX · ASXLast in our picks 2026-10-04 — not in the current list; analysis below is from that screen
Specialty healthcare exposure with potential rerating if operating momentum improves.
Signal breakdown
- ▸Limited biotech specificity and fewer visible catalysts.
- ▾Below 50-day MA (-13.3%)
- ▾Near 52-week low (0% of range)
Is ANO a buy right now?
Trend: ANO is trading below the 50-day average (-7.46%), RSI 17 — oversold territory, with a 3-month return of -22.98%.
Valuation & quality: Advance ZincTek Limited trades on a trailing P/E of 31.0, PEG 0.62, price-to-book 1.08; fundamentals show net margin 11.1%, return on equity 4.2%, revenue growth 8.7% year on year.
Income: trailing dividend yield 3.23%.
Our screen: WATCH (score 0) — Specialty healthcare exposure with potential rerating if operating momentum improves.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -3.10% | -12.60% | -3.60% | +0.00% | +0.00% | -11.30% | -11.30% | -1.60% |
Fundamentals
Technical signals
About Advance ZincTek Limited
Advance ZincTek Limited, together with its subsidiaries, manufactures aluminum oxide powder, and zinc oxide dispersions and powder for use in the personal care sector in Australia, the United States, Canada, Europe, and internationally.
Sector: Basic Materials · Industry: Chemicals · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.